man brain spectra by LCModel and AMARES. Magn Reson 28.
Med 2004;51:904 –912.
17. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Tang-Wai
DF, O'Brien PC, et al. 1H MR spectroscopy in common de- mentias. Neurology 2004;63:1393–1398. 29.
18. Kassubek J, Juengling FD, Hoffmann S, Rosenbohm A, Kurt
A, Jurkat-Rott K, et al. Quantification of brain atrophy in
patients with myotonic dystrophy and proximal myotonic my- opathy: a controlled 3-dimensional magnetic resonance im- 30.
aging study. Neurosci Lett 2003;348:73–76.
19. Kiuchi A, Otsuka N, Namba Y, Nakano I, Tomonaga M.
Presenile appearance of abundant Alzheimer's neurofibril- 31.
lary tangles without senile plaques in the brain in myotonic
dystrophy. Acta Neuropathol 1993;82:1–5.
20. Kornblum C, Reul J, Kress W, Grothe C, Amanatidis N, Klock-32.
gether T, et al. Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2. J Neurol
2004;251:710 –714.
21. Le Ber I, Martinez M, Campion D, Laquerriere A, Betard C,
33.
Bassez G, et al. A non-DM1, non-DM2 multisystem myotonic
disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21–24.
34.
Brain 2004;127:1979 –1992.
22. Lehrl S. Mehrfachwahl-Wortschatz-Intelligenztest MWT-B. Er-35.
langen: Straube; 1978.
23. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W,
Naylor SL, et al. Myotonic dystrophy type 2 caused by a CCTG
36.
expansion in intron 1 of ZNF9. Science 2001;293:864 – 867.
24. Martorell L, Monckton DG, Gamez J, Johnson KJ, Gich I,
Lopez de Munain A, et al. Progression of somatic CTG repeat 37.
length heterogeneity in the blood cells of myotonic dystrophy
patients. Hum Mol Genet 1998;7:307–312.
25. Meola G, Sansone V, Perani D, Colleluori A, Cappa S, Cotelli
M, et al. Reduced cerebral blood flow and impaired visual- 38.
spatial function in proximal myotonic myopathy. Neurology
1999;53:1042–1050.
26. Meola G, Sansone V, Perani D, Scarone S, Cappa S, Dragoni 39.
C, et al. Executive dysfunction and avoidant personality trait
in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2). Neuromuscul Disord 2003;
13:813– 821. 40.
Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR
Biomed 1991;4:47–52.
